Detalhe da pesquisa
1.
A requirement for p120-catenin in the metastasis of invasive ductal breast cancer.
J Cell Sci
; 134(6)2021 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33097605
2.
Immunomodulatory Properties of PI3K/AKT/mTOR and MAPK/MEK/ERK Inhibition Augment Response to Immune Checkpoint Blockade in Melanoma and Triple-Negative Breast Cancer.
Int J Mol Sci
; 23(13)2022 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35806358
3.
Hiding in the dark: pan-cancer characterization of expression and clinical relevance of CD40 to immune checkpoint blockade therapy.
Mol Cancer
; 20(1): 146, 2021 11 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34758832
4.
Novel induction of CD40 expression by tumor cells with RAS/RAF/PI3K pathway inhibition augments response to checkpoint blockade.
Mol Cancer
; 20(1): 85, 2021 06 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34092233
5.
The Duffy antigen receptor for chemokines transports chemokines and supports their promigratory activity.
Nat Immunol
; 10(1): 101-8, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19060902
6.
Intravitreal melphalan hydrochloride vs propylene glycol-free melphalan for retinoblastoma vitreous seeds: Efficacy, toxicity and stability in rabbits models and patients.
Exp Eye Res
; 204: 108439, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33444583
7.
Inhibition of the PI3K/mTOR Pathway in Breast Cancer to Enhance Response to Immune Checkpoint Inhibitors in Breast Cancer.
Int J Mol Sci
; 22(10)2021 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34069042
8.
Correlative studies investigating effects of PI3K inhibition on peripheral leukocytes in metastatic breast cancer: potential implications for immunotherapy.
Breast Cancer Res Treat
; 184(2): 357-364, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32767201
9.
The Yin/Yan of CCL2: a minor role in neutrophil anti-tumor activity in vitro but a major role on the outgrowth of metastatic breast cancer lesions in the lung in vivo.
BMC Cancer
; 17(1): 88, 2017 01 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-28143493
10.
Adaptor protein2 (AP2) orchestrates CXCR2-mediated cell migration.
Traffic
; 15(4): 451-69, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24450359
11.
Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis.
Cancer Cell
; 13(1): 23-35, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18167337
12.
Nf-kappa B, chemokine gene transcription and tumour growth.
Nat Rev Immunol
; 2(9): 664-74, 2002 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-12209135
13.
Phase II trial of bortezomib plus doxorubicin in hepatocellular carcinoma (E6202): a trial of the Eastern Cooperative Oncology Group.
Invest New Drugs
; 32(5): 1017-27, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24890858
14.
Passage-dependent cancerous transformation of human mesenchymal stem cells under carcinogenic hypoxia.
FASEB J
; 27(7): 2788-98, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23568779
15.
The chemokine receptors CXCR1 and CXCR2 couple to distinct G protein-coupled receptor kinases to mediate and regulate leukocyte functions.
J Immunol
; 189(6): 2824-32, 2012 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22869904
16.
CXCR2 chemokine receptor - a master regulator in cancer and physiology.
Trends Mol Med
; 30(1): 37-55, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37872025
17.
Harnessing the potential of CD40 agonism in cancer therapy.
Cytokine Growth Factor Rev
; 75: 40-56, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38102001
18.
Endogenous pAKT activity is associated with response to AKT inhibition alone and in combination with immune checkpoint inhibition in murine models of TNBC.
Cancer Lett
; 586: 216681, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38311054
19.
Nanoparticle Retinoic Acid-Inducible Gene I Agonist for Cancer Immunotherapy.
ACS Nano
; 18(18): 11631-11643, 2024 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38652829
20.
Programable Albumin-Hitchhiking Nanobodies Enhance the Delivery of STING Agonists to Potentiate Cancer Immunotherapy.
Res Sq
; 2024 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38766114